Cargando…

Review of Drug Development Guidance to Treat Chronic Obstructive Pulmonary Disease: US and EU Perspectives

Chronic obstructive pulmonary disease (COPD) remains a leading cause of death worldwide, yet only one new drug class has been approved in the last decade. However, resurgence in COPD treatment has been recently fueled by a greater understanding of the pathophysiology and natural history of the disea...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Haarst, Aernout, McGarvey, Lorcan, Paglialunga, Sabina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896238/ https://www.ncbi.nlm.nih.gov/pubmed/31334840 http://dx.doi.org/10.1002/cpt.1540

Ejemplares similares

Periodontal status and chronic obstructive pulmonary disease (COPD) exacerbations: a systematic review
por: Kelly, Niamh, et al.
Publicado: (2021)

Mechanisms and Rationale for Targeted Therapies in Refractory and Unexplained Chronic Cough
por: Mazzone, Stuart B., et al.
Publicado: (2020)

Recent progress in the management of chronic cough
por: Song, Woo-Jung, et al.
Publicado: (2020)

Chronic cough: new insights and future prospects
por: Morice, Alyn, et al.
Publicado: (2021)

From bench to bedside: The role of cough hypersensitivity in chronic cough
por: Drake, Matthew G., et al.
Publicado: (2023)

The Effect of Aclidinium on Symptoms Including Cough in Chronic Obstructive Pulmonary Disease: A Phase 4, Double-Blind, Placebo-controlled, Parallel-Group Study
por: Smith, Jaclyn A., et al.
Publicado: (2019)

One-Year Safety of Olodaterol Once Daily via Respimat® in Patients with GOLD 2–4 Chronic Obstructive Pulmonary Disease: Results of a Pre-Specified Pooled Analysis
por: McGarvey, Lorcan, et al.
Publicado: (2015)

COUGH: consolidating a mature field for the next 5 years
por: Chung, Kian Fan, et al.
Publicado: (2011)

Guidance for pediatric use in prescription information for novel medicinal products in the EU and the US
por: Christiansen, Helle, et al.
Publicado: (2022)

Guidance for the Better Care of Patients with Chronic Obstructive Pulmonary Disease
por: Calverley, Peter M. A.
Publicado: (2020)

Exacerbations of Chronic Obstructive Pulmonary Disease
por: Garvey, Christine, et al.
Publicado: (2012)

Treating acute cough: wet versus dry – have we got the paradigm wrong?
por: Morice, Alyn H., et al.
Publicado: (2015)

Objective and Subjective Measurement of Cough in Asthma: A Systematic Review of the Literature
por: Holmes, Joshua, et al.
Publicado: (2022)

Prevalence of psychomorbidity among patients with chronic cough
por: McGarvey, Lorcan PA, et al.
Publicado: (2006)

Clinical Research Fellow
por: Addy, Charlotte, et al.
Publicado: (2019)

The relationship between the Leicester cough questionnaire, eosinophilic airway inflammation and asthma patient related outcomes in severe adult asthma
por: Natarajan, Sushiladevi, et al.
Publicado: (2017)

Adverse perception of cough in patients with severe asthma: a discrete choice experiment
por: Holmes, Joshua, et al.
Publicado: (2023)

Trypsin-Like Proteases and Their Role in Muco-Obstructive Lung Diseases
por: Carroll, Emma L., et al.
Publicado: (2021)

Comparison of US and EU Prices for Orphan Drugs in the Perspective of the Considered US Orphan Drugs Act Modifications and Discussed Price-Regulation Mechanisms Adjustments in US and European Union
por: Żelewski, Paweł, et al.
Publicado: (2022)

New Perspectives on Chronic Obstructive Pulmonary Disease
por: Celli, Bartolome R, et al.
Publicado: (2022)

Idiopathic chronic cough: a real disease or a failure of diagnosis?
por: McGarvey, LPA
Publicado: (2005)

An observational study to determine the relationship between cough frequency and markers of inflammation in severe asthma
por: Holmes, Joshua, et al.
Publicado: (2022)

Cough hypersensitivity and chronic cough
por: Chung, Kian Fan, et al.
Publicado: (2022)

Burden of chronic cough in the UK: results from the 2018 National Health and Wellness Survey
por: McGarvey, Lorcan, et al.
Publicado: (2023)

QT Assessment in Early Drug Development: The Long and the Short of It
por: Lester, Robert M., et al.
Publicado: (2019)

Acute and chronic cough
por: McGarvey, L.P.A., et al.
Publicado: (2004)

Acute Respiratory Distress Syndrome Caused by Mycoplasma Pneumoniae Diagnosed by Polymerase Chain Reaction
por: Yew, Peter, et al.
Publicado: (2012)

Cost-effectiveness of Pulmonary Rehabilitation Among US Adults With Chronic Obstructive Pulmonary Disease
por: Mosher, Christopher L., et al.
Publicado: (2022)

Chronic Obstructive Pulmonary Disease and Arthritis Among US Adults, 2016
por: Liu, Yong, et al.
Publicado: (2019)

Macroeconomic and health care aspects of the coronavirus epidemic: EU, US and global perspectives
por: Welfens, Paul J. J.
Publicado: (2020)

Fake reviews on online platforms: perspectives from the US, UK and EU legislations
por: Martínez Otero, Juan María
Publicado: (2021)

EU GDPR & EU-US Privacy Shield: A Pocket Guide
por: Calder, Alan
Publicado: (2017)

EU GDPR & EU-U.S. Privacy Shield: A pocket guide
por: Calder, Alan
Publicado: (2019)

The Serpin Superfamily and Their Role in the Regulation and Dysfunction of Serine Protease Activity in COPD and Other Chronic Lung Diseases
por: Kelly-Robinson, Gillian A., et al.
Publicado: (2021)

Role of pulmonary rehabilitation in chronic obstructive pulmonary disease - a historical perspective
por: Stavarache, Ioan Emanuel, et al.
Publicado: (2022)

EU guidance impedes humanitarian action to prevent COVID-19 in Syria
por: Hussain, Hamid Yahiya, et al.
Publicado: (2020)

A Mitochondrial Perspective of Chronic Obstructive Pulmonary Disease Pathogenesis
por: Kang, Min-Jong, et al.
Publicado: (2016)

Early chronic obstructive pulmonary disease: A new perspective
por: Lu, Huan-Huan, et al.
Publicado: (2021)

Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials
por: McGarvey, Lorcan, et al.
Publicado: (2016)

Comprehensive assessment of the safety of olodaterol 5 µg in the Respimat(®) device for maintenance treatment of COPD: comparison with the long-acting β(2)-agonist formoterol
por: Koch, Andrea, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a5i61q8h45i7d482opjb8k6fgq